Inovalon (NASDAQ:INOV) will release its earnings data after the market closes on Tuesday, February 20th. Analysts expect Inovalon to post earnings of $0.07 per share for the quarter.
Shares of Inovalon (NASDAQ INOV) opened at $12.35 on Tuesday. Inovalon has a twelve month low of $10.45 and a twelve month high of $17.80. The firm has a market capitalization of $1,800.00 and a PE ratio of 102.92. The company has a quick ratio of 5.62, a current ratio of 5.62 and a debt-to-equity ratio of 0.31.
In other Inovalon news, President Robert A. Wychulis sold 85,828 shares of the firm’s stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $15.54, for a total value of $1,333,767.12. Following the completion of the transaction, the president now owns 466,286 shares in the company, valued at approximately $7,246,084.44. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Shauna L. Vernal sold 44,270 shares of the firm’s stock in a transaction dated Tuesday, January 23rd. The stock was sold at an average price of $14.00, for a total value of $619,780.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 136,006 shares of company stock valued at $2,048,134. 48.28% of the stock is owned by corporate insiders.
WARNING: This report was published by American Banking News and is owned by of American Banking News. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.americanbankingnews.com/2018/02/13/inovalon-inov-scheduled-to-post-earnings-on-tuesday.html.
Inovalon Company Profile
Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with MarketBeat.com's FREE daily email newsletter.